Breaking News
Investing Pro 0
Cyber Monday SALE: Up to 54% OFF InvestingPro+ CLAIM OFFER
Close

AstraZeneca PLC ADR (AZNN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,256.61 0.00    0.00%
23/11 - Closed. Currency in MXN ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 1,199.00 / 1,297.00
  • Day's Range: 1,256.61 - 1,280.00
Type:  Equity
Market:  Mexico
ISIN:  US0463531089 
S/N:  046353108
AstraZeneca ADR 1,256.61 0.00 0.00%

AZNN Balance Sheet

 
Featured here, the Balance Sheet for AstraZeneca PLC ADR, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
30/09
2022
30/06
2022
31/03
2021
31/12
Total Current Assets 20224 20917 22647 26244
Cash and Short Term Investments 4522 4887 5823 6398
Cash - - - -
Cash & Equivalents 4458 4817 5762 6329
Short Term Investments 64 70 61 53
Total Receivables, Net 10061 9612 9050 8795
Accounts Receivables - Trade, Net 9336 8908 8683 6031
Total Inventory 5078 6220 7624 8983
Prepaid Expenses - - - 1512
Other Current Assets, Total 563 198 150 556
Total Assets 94185 96579 100273 105363
Property/Plant/Equipment, Total - Net 9227 9627 10015 10171
Property/Plant/Equipment, Total - Gross - - - 18495
Accumulated Depreciation, Total - - - -8324
Goodwill, Net 19707 19821 19963 19997
Intangibles, Net 39585 39900 41265 42387
Long Term Investments 1102 1180 1237 1262
Note Receivable - Long Term 725 704 367 2764
Other Long Term Assets, Total 904 994 951 972
Other Assets, Total -920 1016 2980 5143
Total Current Liabilities 24850 21815 22740 22594
Accounts Payable 16842 16983 17040 2824
Payable/Accrued - - - -
Accrued Expenses - - - 12358
Notes Payable/Short Term Debt 743 747 805 411
Current Port. of LT Debt/Capital Leases 5795 2563 2348 2481
Other Current liabilities, Total 1470 1522 2547 4520
Total Liabilities 59031 60628 63914 66076
Total Long Term Debt 24737 28078 29592 30471
Long Term Debt 24069 27393 28868 29717
Capital Lease Obligations 668 685 724 754
Deferred Income Tax 3479 5275 5626 6206
Minority Interest 20 19 19 19
Other Liabilities, Total 846 386 854 2085
Total Equity 35154 35951 36359 39287
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 387 387 387 387
Additional Paid-In Capital 35137 35134 35131 35126
Retained Earnings (Accumulated Deficit) -2471 -1657 -1228 3644
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 2101 2087 2069 130
Total Liabilities & Shareholders' Equity 94185 96579 100273 105363
Total Common Shares Outstanding 1548 1549 1548 1549.4
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about Astrazeneca PLC DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Gab Lavarro
Gab Lavarro Feb 11, 2021 12:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
do not buy this stock, it's a trap
Jim Dawoud
Jim Dawoud Feb 08, 2021 21:16
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Junk like pfizer
Danny Dambrosio
Danny Dambrosio Aug 23, 2020 10:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why is this stock so stagnant? even with good news it seems to drop.
arturo cota
arturo cota Aug 07, 2020 11:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Japan, AstraZeneca agree on 120 mil. COVID-19 vaccine dose supply KYODO NEWS - 2 hours ago - 21:49 | All, Japan, Coronavirus
Danny Dambrosio
Danny Dambrosio Aug 07, 2020 11:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I dont get how this company pumps out good news and a potential merger and the stock moves by pennies. what will it take for this stock to jump?
Shankar Thapa
Shankar Thapa Jul 30, 2020 15:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Get into it before FDA approves vaccine
Kamaluddin Shakiri
Kamaluddin Shakiri May 21, 2020 10:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is it too late to get in?
Arjun Raj
Arjun Raj May 21, 2020 10:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Not really man,Its just the beginning.Its gonna be late 3 weeks after.
Danny Dambrosio
Danny Dambrosio May 21, 2020 10:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think it's a good time. this stock is stable historically and pays dividends. I bought at 62 so I'm down big but have faith it will be good long term.
Bud and Butter Online Custom Edibles
Bud and Butter Online Custom Edibles May 21, 2020 10:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email